UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts

Pediatric pulmonology, 2020-07, Vol.26 (4), p.233-240

2020

Link zum Volltext

Verfügbarkeit prüfen

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

Clinical microbiology and infection, 2018-06, Vol.24, p.S10-S20

2018

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance

Journal of rheumatology. Supplement, 2014-05, Vol.91, p.47

2014

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects

Pulmonology, 2021-03, Vol.27 (2), p.151-165

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of the global COVID-19 outbreak on the management of other communicable diseases

The international journal of tuberculosis and lung disease, 2020-05, Vol.24 (5), p.547-548

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 effects on tuberculosis care in Sierra Leone

Pulmonology, 2021-01, Vol.27 (1), p.67-69

2021

Link zum Volltext

Verfügbarkeit prüfen

Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis

Tuberculosis (Edinburgh, Scotland), 2017-09, Vol.106, p.38-43

2017

Link zum Volltext

Verfügbarkeit prüfen

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

The European respiratory journal, 2009-05, Vol.33 (5), p.956-973

2009

Link zum Volltext

Verfügbarkeit prüfen

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

The European respiratory journal, 2011, Vol.37 (1), p.88-99

2011

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes

The international journal of tuberculosis and lung disease, 2023-04, Vol.27 (4), p.284

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis

Clinical microbiology and infection, 2019-02, Vol.25 (2), p.169-177

2019

Link zum Volltext

Verfügbarkeit prüfen

Making IGRA testing easier: First performance report of QIAreach QFT for tuberculosis infection diagnosis

Pulmonology, 2022-01, Vol.28 (1), p.4-5

2022

Link zum Volltext

Verfügbarkeit prüfen

VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB

The international journal of tuberculosis and lung disease, 2022-01, Vol.26 (1), p.65-68

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical standards for the diagnosis, treatment and prevention of TB infection

The international journal of tuberculosis and lung disease, 2022-03, Vol.26 (3), p.190-205

2022

Link zum Volltext

Verfügbarkeit prüfen

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

The European respiratory journal, 2009-03, Vol.33 (3), p.586-593

2009

Link zum Volltext

Verfügbarkeit prüfen

Managing latent tuberculosis infection and tuberculosis in children

Pulmonology, 2018-03, Vol.24 (2), p.106-114

2018

Link zum Volltext

Verfügbarkeit prüfen

Blood and urine inducible protein 10 as potential markers of disease activity

The international journal of tuberculosis and lung disease, 2016-11, Vol.20 (11), p.1554-1561

2016

Link zum Volltext

Verfügbarkeit prüfen

Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection

Journal of internal medicine, 2018-03, Vol.283 (3), p.303-313

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection

The European respiratory journal, 2010-07, Vol.36 (1), p.135-142

2010

Link zum Volltext

Verfügbarkeit prüfen

Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection

The European respiratory journal, 2010-03, Vol.35 (3), p.619-626

2010

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 effect on tuberculosis care in Sierra Leone: Are we in the recovery phase?

Pulmonology, 2023-05, Vol.29 (3), p.244-246

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls

Clinical microbiology and infection, 2010-08, Vol.16 (8), p.1282-1284

2010

Link zum Volltext

Verfügbarkeit prüfen

Lack of Response to HBHA in HIV‐Infected Patients with Latent Tuberculosis Infection

Scandinavian journal of immunology, 2016-12, Vol.84 (6), p.344-352

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic imaging of hepatic tuberculosis: case series

The international journal of tuberculosis and lung disease, 2018-07, Vol.22 (7), p.779-787

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Humans
(98)
Life Sciences & Biomedicine
(98)
Infectious Diseases
(49)
Male
(46)
Female
(44)
Tuberculosis
(44)
Adult
(43)
Biological And Medical Sciences
(33)
Immunology
(32)
Middle Aged
(31)
Medical Sciences
(29)
Respiratory System
(29)
Mycobacterium Tuberculosis
(27)
Microbiology
(23)
Tuberculosis - Diagnosis
(21)
Aged
(18)
Mycobacterium Tuberculosis - Immunology
(17)
Human Immunodeficiency Virus
(15)
Bacterial Diseases
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance

Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects

Impact of the global COVID-19 outbreak on the management of other communicable diseases

COVID-19 effects on tuberculosis care in Sierra Leone

Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes

Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis

Making IGRA testing easier: First performance report of QIAreach QFT for tuberculosis infection diagnosis

VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB

Clinical standards for the diagnosis, treatment and prevention of TB infection

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases

Managing latent tuberculosis infection and tuberculosis in children

Blood and urine inducible protein 10 as potential markers of disease activity

Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection

Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection

COVID-19 effect on tuberculosis care in Sierra Leone: Are we in the recovery phase?

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine

Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls

Lack of Response to HBHA in HIV‐Infected Patients with Latent Tuberculosis Infection

Diagnostic imaging of hepatic tuberculosis: case series

Suchergebnisse filtern